Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Imaging Brain Chemistry and Function in Neuropsychiatric Disorders
Peter C Williamson
PDF

In Review
In vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders
Jeffrey A Stanley
PDF

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging
Cheryl L Grady, Michelle L Keightley

PDF

Review Papers
Attention-Deficit Hyperactivity Disorder: Critical Appraisal of Extended Treatment Studies

Russell Schachar, Alejandro R Jadad, Mary Gauld, Michael Boyle, Lynda Booker, Anne Snider, Marie Kim, Charles Cunningham

PDF

Clinical Implications of a Link Between Fetal Alcohol Spectrum Disorder and Attention-Deficit Hyperactivity Disorder
Kieran D O'Malley, Jo Nanson

PDF

Original Research
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment

Dennis Wardman, Nadia Khan, Nady el-Guebaly

PDF

The Impact of Latitude on the Prevalence of Seasonal Depression
Anthony J Levitt, Michael H Boyle

PDF

Preliminary Assessment of Intrahemispheric QEEG Measures in Bipolar Mood Disorders
OJ Oluboka, SL Stewart, V Sharma, D Mazmanian, E Persad

PDF

Brief Communciation
Hepatic Adverse Reactions Associated With Nefazodone
Donna E Stewart

PDF


Book Reviews
(PDF - all reviews)

Functional Neuroimaging in Child Psychiatry

Handbook of Cultural Psychiatry

The Empathetic Healer: An Endangered Species?

Cognitive Rehabilitiation: An Integrative Neuropsychological Approach

The Madness of Adam and Eve: How Schizophrenia Shaped Humanity


Letters to the Editor
(PDF - all letters)

Evidence-Based Psychiatry

Evidence-Based Psychiatry: Response

Research Ethics and Forensic Psychiatry: A Comment on Regehr and Others

Research Ethics and Forensic Psychiatry: Response

Repetitive Transcranial Magnetic Stimulation is Useful for Maintenance Treatment

The Mood Disorder Questionnaire for Assessing Bipolar Spectrum Disorder Frequency

Capgras Syndrome and Blindness: Against the Prosopagnosia Hypothesis

Re: New Centry: Overcoming Stigma, Respecting Differences—Dr Myers' Superlative Presidential Address

Steroid-Induced Psychosis Treated With Risperidone

Original Research

Preliminary Assessment of Intrahemispheric QEEG Measures in Bipolar Mood Disorders

OJ Oluboka, MBBS, FRCPC1, SL Stewart, PhD2, V Sharma, MBBS, FRCPC3,
D Mazmanian, PhD4, E Persad, MBBS, FRCPC5

 

Objective: This study assessed the quantitative electroenchephalographic (QEEG) absolute power and coherence differences between a group of patients with bipolar I mood disorder (BMD I) and a group of patients with schizophrenia. We also examined the correlation between QEEG measures and family history of BMD.

Method: Using the National Institutes of Mental Health (NIMH) Global Rating Scale, we rated 18 adult inpatients with a DSM-III-R diagnosis of BMD I for the severity of the current episode. We also collected data on the family history of the illness. This group was then matched for age, sex, and handedness with an equal number of inpatients with a DSM-III-R diagnosis of schizophrenia. QEEG absolute power and coherence was calculated for the alpha bandwidth (8.0 to 12.0 Hz), assessed at 18 pairs of electrodes in both hemispheres during resting, eyes-closed condition in all the patients.

Results: The patients with schizophrenia showed significantly higher coherence (P = 0.047) at 6 pairs of electrodes on the right side. The group with BMD showed significantly higher power (P = 0.042) at 2 pairs of electrodes on the right side. Correlational analysis showed that QEEG measures were significantly correlated (P = 0.01) with positive family history of BMD.

Conclusion: These findings suggest that the patients with BMD are more disorganized in the right anterior hemisphere and that there is a significant positive correlation between the QEEG measures and the presence of family history of BMD. Further studies in a larger sample are required to confirm these preliminary findings.

(Can J Psychiatry 2002;47;368–374)

Clinical Implications

  • Patients with bipolar mood disorder (BMD) were more disorganized in the right anterior hemisphere, compared with patients with schizophrenia.
  • There was a significant correlation between family history of BMD and QEEG measures.
  • These findings are in keeping with positron emission tomography (PET) and other EEG studies.

Limitations

  • The sample was small.
  • The patient group was mixed (there were patients with BMD with depression and BMD with mania).
  • Medicated patients with schizophrenia were used as the control group.

Key Words: QEEG, bipolar mood disorder, family history

Résumé : Évaluation préliminaire des mesures EEGQ intrahémisphériques pour les troubles bipolaires


An association between epileptiform disorders and psychopathology has long been recognized (1). Flor-Henry reported left temporal EEG abnormalities in schizophrenia patients and bi-temporal, but mainly right temporal, dysrhythmia in mood disorders (2). Flor-Henry and Koles postulated that, in the psychoses, there is disorganization of the right hemisphere that is least severe in depression, intermediate in mania, and maximal in schizophrenia (3). They considered left hemisphere disorganization to also exist in both mania and schizophrenia.

Cook and others found that bipolar patients with abnormal EEGs had a significantly negative family history of mood disorder, compared with patients with normal EEGs (4). They confirmed previous findings by Dalen (5), Hays (6), and Kadzmas and Winokur (7) in the postulation of “acquired mania” that occurs independently of a genetic loading. However, Dewan and others were unable to replicate earlier reports suggesting lateralization of these abnormalities or the negative correlation between EEG abnormalities and family history of mood disorder (8). Levy and others (9) found a positive family history of mood disorder in their 3 patients with rapid-cycling Bipolar Mood Disorder (BMD) with EEG paroxysmal sharp waves, which also seems to contradict the earlier reports. A major limitation of these studies is the fact that the clinical application of the conventional EEG is limited by the qualitative evaluation of the results.

The introduction of microcomputers and the quantitative analysis of EEG (QEEG) variables with appropriate statistical methods offer more objective and reliable mechanisms for evaluating and extracting diagnostic and discriminating EEG variables. The clinical sensitivity of electroencephalography to psychiatric disorders has been significantly enhanced with the advent of QEEG. Despite several methodological limitations, QEEG variables have been used to investigate brain activity in psychiatric disorders. Relations between psychiatric diagnostic categories and some QEEG variables have been examined in the attempt to characterize the QEEG abnormalities specific to a particular diagnosis (10). QEEG coherence and power provide measures of the correlation and intensity between 2 EEG signals for any given frequency band. Coherence gives an indication of which particular brain regions are correlated (or working together) in either the resting or activated state. Power is the QEEG-derived parameter of the EEG voltage amplitude, which indicates the intensity of the wave between particular brain regions in either the resting or activated state.

Using QEEG variables, Shagass and others reported that patients with schizophrenia and mania were alike in their differences from control subjects, although the differences were of larger magnitude for patients with mania (11). Further, they found no important differences between the patients with schizophrenia and those with mania. Kano and others found that patients with mania displayed decreased alpha power at F7 and increased beta at F8, compared with depression patients (12). Koles and others conducted QEEG studies of hemispheric relations between patients with schizophrenia and those with mood disorders by examining spatial patterns including power, coherence, and phase relations (13). Left hemispheric disorganization occurred in both groups, but more so in the patients with schizophrenia. Small and others’ study compared a small subsample of drug-free patients with mania with normal control subjects and revealed lower QEEG amplitudes in the left anterior and midtemporal regions in the patients (14). Although some investigators indicated that some EEG measures are heavily determined by trait factors, including heredity, others concluded that, given the different activation levels among diagnostic groups, the measures reflect state more than trait factors (11,15). These results remain inconclusive.

Our study assessed the QEEG absolute power and coherence differences between a group of patients with BMD I and a group with schizophrenia. We also examined the correlation between QEEG measures and family history of BMD, testing the hypothesis that there is a significant positive association between QEEG measures and a positive family history of BMDs.

 

Method

Subjects

We included in the study 18 inpatients meeting DSM-III-R (16) criteria for BMD. None had a prior history of neonatal asphyxia, epilepsy, head injury, schizophrenia, delirium, or dementia.

All the patients were assessed by a psychiatrist using a structured clinical interview. Approximate length of illness was 13 years. Symptom severity was rated using the National Institutes of Mental Health (NIMH) Global Rating Scales (17). Subjects were on an average daily dosage of 1380 mg lithium. All as-needed (PRN) medications (for example, antipsychotics and benzodiazepines) were held for at least 48 hours prior to EEG recording. The presence or absence of family history of BMD in first-degree relatives was also documented via patient reports and available clinical information. All patients were in the active manic-depressive or mixed phase at the time of study.

Eighteen inpatients meeting DSM-III-R criteria for schizophrenia (chronic) served as a comparison group. All were diagnosed using clinical information and an interview with a psychiatrist using the Structured Clinical Interview for DSM-III-R (SCID) (18). Approximate length of illness was 9 years. In this group, medication averaged 580.6 mg chlorpromazine equivalents daily. This sample was drawn from a larger group of patients (n = 30) on which we have previously published reports (19,20). In previous reports, no differences were found between schizophrenia patients and matched normal control subjects on measures of resting QEEG indices (that is, alpha bandwidth) in either eyes-open or eyes-closed conditions. For this reason, we did not include a normal control group in the present study.

The subjects with schizophrenia and those with BMD were matched on the variables of age, sex, and handedness. All subjects provided informed, written consent prior to participation in the study.

Quantitative Electroencephalograpy (QEEG)

We obtained EEG data using a QSI 9000 computer-based acquisition system with Grass gold-plated cup electrodes positioned according to the International 10/20 system (21) using that employs a linked-ears reference (Figure 1). All subjects underwent EEG recording in the morning hours. Electrode impedences were not greater than 5000 ohms. Artefacts caused by eye movement (monitored via electro-olfactogram [EOG]), drowsiness, muscle tension, or technical difficulties were excluded via an automatic-rejection computer program and by visual inspection of the record. Because it was extremely difficult to maintain a continuous state of immobility in the patients with BMD, the minimum criteria for maintaining a sample of EEG for analysis was 20 seconds of artefact-free EEG data. The samples were averaged at 2.5 second epochs, digitized at a rate of 102.4 samples per second, and filtered at 0.5 to 30 Hz. Each digitized epoch of eyes-closed EEG data was quantified using a Fast Fourier Transformation (FFT) (22). FFT amplitude and spectra were averaged and summed together, and individual bandwidths were computed. EEG alpha (8 to 12 Hz) bandwidth power and coherence were calculated for 18 pairs of electrodes in both left and right hemispheres (F3F7, F3C3, F3T3, F3T5, F3P3, F3O1, F7C3, F7T3, F7T5, F7P3, F7O1, T5C3, T5T3, T5P3, T5O1, P3C3, P3T3, P3O1, and homologous locations in the right hemisphere).

Statistical Analysis

The clinical and demographic characteristics of both groups were evaluated using 1-way analysis of variance (ANOVA) and SPSS software (23). Between-group, resting eyes-closed measures of alpha power and coherence were also assessed using 1-way ANOVA at the 18 pairs of electrodes in both left and right hemispheres. A Pearson r correlation analysis between ratings of family history of BMD and EEG power and coherence measures within the BMD subjects was also conducted.